Information Provided By: 
Fly News Breaks for June 30, 2015
JUNO, CELG
Jun 30, 2015 | 09:05 EDT
Canaccord noted the deal between Celgene (CELG) and Juno Therapeutics (JUNO) and said the current deal structure may mean 2020 earnings may have to be adjusted lower as some of the company's programs are not eligible for a 50/50 split. Canaccord said Celgene may simply buy the rest of Juno to gain 100% of all the programs worldwide and reiterated its Buy rating and $156 price target on Celgene shares.
News For CELG;JUNO From the Last 2 Days
There are no results for your query CELG;JUNO
